Document is current
Any future updates will be listed below
-
Authors
Sundaresan, Vaanathi
Zamboni, Giovanna
Dineen, Robert A.
Auer, Dorothee P.
Sotiropoulos, Stamatios N.
Sprigg, Nikola
Jenkinson, Mark
Griffanti, Ludovica https://orcid.org/0000-0002-0540-9353
-
Funding
Funding for this research was provided by:
NIHR Oxford Health Biomedical Research Centre (NIHR203316)
Wellcome Trust (203139/Z/16/Z; 203139/A/16/Z, 215573/Z/19/Z)
EPSRC Centre for Doctoral Training in Medical Imaging (EP/L016052/1)
NIHR Nottingham Biomedical Research Centre
British Heart Foundation (PG/14/96/31262)
Health Technology Assessment Programme
The Wellcome Trust DBT India Alliance (IA/E/22/1/506763)
Pratiksha Trust, Bangalore, India (FG/PTCH-23-1004)
Italian Ministry of Education (Dipartimenti di eccellenza 2018-2022)
NIHR Oxford Biomedical Research Centre
Alzheimer's Association (AARF-21-846366)
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 13 December 2024
First Online: 13 January 2025
Declarations
:
: The TICH-2 trial obtained ethical approval from the East Midlands (Nottingham 2) NHS Research Ethics Committee (Reference: 11/EM/0369), and the amendment to allow the TICH-2 MRI sub-study was approved in April 2015 (amendment number SA02/15). The patients/participants provided their written informed consent to participate in this study.
: Not applicable.
: MJ and LG receive royalties from licensing of FSL to non-academic, commercial users, via Oxford University Innovation (OUI), the technology transfer company of the University of Oxford. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
